Xianteng Yang

403 total citations
25 papers, 292 citations indexed

About

Xianteng Yang is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology. According to data from OpenAlex, Xianteng Yang has authored 25 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Xianteng Yang's work include Radiopharmaceutical Chemistry and Applications (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xianteng Yang is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xianteng Yang collaborates with scholars based in China, Ethiopia and United States. Xianteng Yang's co-authors include Haifeng Huang, Hua Zhu, Zhi Yang, Quan Xie, Xiaobin Tian, Li Sun, Senlei Li, Tao Li, Cheng Chen and Xiaoyuan Gong and has published in prestigious journals such as PLoS ONE, Medicine and Bioconjugate Chemistry.

In The Last Decade

Xianteng Yang

21 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianteng Yang China 10 87 72 56 52 40 25 292
Tong Yang China 10 58 0.7× 113 1.6× 41 0.7× 14 0.3× 79 2.0× 28 289
Nianfeng Sun China 11 58 0.7× 53 0.7× 72 1.3× 8 0.2× 156 3.9× 29 356
Wusheng Kan China 10 173 2.0× 37 0.5× 43 0.8× 11 0.2× 95 2.4× 26 378
Shuwei Zhou China 12 33 0.4× 86 1.2× 28 0.5× 58 1.1× 100 2.5× 43 364
Stanislav Žiaran Slovakia 12 129 1.5× 56 0.8× 68 1.2× 7 0.1× 86 2.1× 32 327
Caifang Ni China 8 96 1.1× 133 1.8× 32 0.6× 13 0.3× 50 1.3× 21 274
Gailutė Kirdaitė Lithuania 9 21 0.2× 74 1.0× 22 0.4× 22 0.4× 62 1.6× 20 348
Jonas Wilbs Switzerland 7 24 0.3× 51 0.7× 25 0.4× 57 1.1× 163 4.1× 12 340
Gary K. Shooter Australia 10 53 0.6× 73 1.0× 49 0.9× 25 0.5× 138 3.5× 18 346
Biying Huang China 14 55 0.6× 262 3.6× 108 1.9× 15 0.3× 104 2.6× 32 422

Countries citing papers authored by Xianteng Yang

Since Specialization
Citations

This map shows the geographic impact of Xianteng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianteng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianteng Yang more than expected).

Fields of papers citing papers by Xianteng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianteng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianteng Yang. The network helps show where Xianteng Yang may publish in the future.

Co-authorship network of co-authors of Xianteng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianteng Yang. A scholar is included among the top collaborators of Xianteng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianteng Yang. Xianteng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Rui Guo, Huimao Zhang, et al.. (2025). [177Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma. Bioconjugate Chemistry. 36(3). 588–596.
2.
Yang, Xianteng, Zhirui Zeng, Futao Liu, et al.. (2025). 124 I‐labelled BMSC‐Derived Extracellular Vesicles Deliver CRISPR/Cas9 Ribonucleoproteins With a GFP‐Reporter System to Inhibit Osteosarcoma Proliferation and Metastasis. Journal of Extracellular Vesicles. 14(7). e70130–e70130. 2 indexed citations
3.
Yang, Xianteng, et al.. (2025). Synthesis and Construction of I-124 Labeled Small Molecular Probe for Noninvasive PET Imaging of CAIX Expression. Molecular Imaging and Biology. 27(3). 485–494.
4.
Chen, Qian, Teli Liu, Qian Zhang, et al.. (2025). Hypoxia Inducible Factor‐1α Specific Probe for Tumor Hypoxia Positron Emission Tomography Imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 68(11-12). e4163–e4163.
5.
Zhou, Nina, Zhen Wang, Teli Liu, et al.. (2024). Construction and Application of a PD-L1-Targeted Multimodal Diagnostic and Dual-Functional Theranostics Nanoprobe. International Journal of Nanomedicine. Volume 19. 5479–5492. 4 indexed citations
6.
Guo, Qian, Chuanke Zhao, Xiangyu Gao, et al.. (2023). One-Minute Iodine Isotope Labeling Technology Enables Noninvasive Tracking and Quantification of Extracellular Vesicles in Tumor Lesions and Intact Animals. Molecular Pharmaceutics. 20(7). 3672–3682. 10 indexed citations
7.
Li, Wen, Lei Xia, Xiaoyi Guo, et al.. (2021). Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models. Frontiers in Oncology. 11. 778728–778728. 6 indexed citations
8.
Zhang, Jin, et al.. (2021). Total hip arthroplasty for tuberculosis: a case series. Annals of Palliative Medicine. 10(1). 495–500. 6 indexed citations
9.
Huang, Haifeng, Hua Zhu, Quan Xie, et al.. (2020). Evaluation of 124I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice. Acta Pharmaceutica Sinica B. 10(7). 1321–1330. 27 indexed citations
10.
Wang, Fan, Xianteng Yang, Hua Zhu, Zhi Yang, & Taiwei Chu. (2019). Synthesis and bioevaluation of novel radioiodinated PEG-modified 2-nitroimidazole derivatives for tumor hypoxia imaging. Journal of Radioanalytical and Nuclear Chemistry. 321(3). 943–954. 6 indexed citations
11.
Xu, Xiaoxia, Teli Liu, Fei Liu, et al.. (2019). Synthesis and evaluation of 64Cu-radiolabeled NOTA-cetuximab (64Cu-NOTA-C225) for immuno-PET imaging of EGFR expression. Chinese Journal of Cancer Research. 31(2). 400–409. 3 indexed citations
12.
Yang, Xianteng, Fan Wang, Hua Zhu, Zhi Yang, & Taiwei Chu. (2019). Synthesis and Bioevaluation of Novel [18F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging. Molecular Pharmaceutics. 16(5). 2118–2128. 16 indexed citations
13.
Li, Tao, Xiongbo Song, Xianteng Yang, et al.. (2019). Preparation and characterization of methacrylated gelatin/bacterial cellulose composite hydrogels for cartilage tissue engineering. Regenerative Biomaterials. 7(2). 195–202. 83 indexed citations
14.
Huang, Haifeng, Hua Zhu, Xianteng Yang, et al.. (2019). [Progress in research on tumor immune PD-1/PD-L1 signaling pathway in malignant bone tumors].. PubMed. 41(6). 410–414. 3 indexed citations
15.
Yang, Xianteng, et al.. (2019). [Early functional recovery of direct anterior approach versus anterolateral approach for total hip arthroplasty].. PubMed. 51(2). 268–272. 4 indexed citations
17.
Huang, Haifeng, et al.. (2018). The effect of anticoagulants on venous thrombosis prevention after knee arthroscopy: a systematic review. International Orthopaedics. 43(10). 2303–2308. 9 indexed citations
18.
Huang, Haifeng, Xianteng Yang, Li Sun, et al.. (2018). Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis. PLoS ONE. 13(6). e0197868–e0197868. 10 indexed citations
19.
Huang, Haifeng, Quan Xie, Xianteng Yang, et al.. (2017). Mobile C-arm CT scan in surgery for thoracolumbar burst fractures of type A3. Zhonghua chuangshang guke zazhi. 19(9). 810–813. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026